Get the Stockscreener App
2.18
0.93%
0.02
After Hours:
2.18
Nucana Plc Adr stock is traded at $2.18, with a volume of 24,513.
It is up +0.93% in the last 24 hours and up +14.14% over the past month.
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
See More
Previous Close:
$2.16
Open:
$2.22
24h Volume:
24,513
Relative Volume:
0.42
Market Cap:
$9.07M
Revenue:
-
Net Income/Loss:
$-38.99M
P/E Ratio:
-0.0162
EPS:
-134.6096
Net Cash Flow:
$-9.67M
1W Performance:
+14.74%
1M Performance:
+14.14%
6M Performance:
-59.33%
1Y Performance:
-98.75%
1-Day Range:
$2.16
$2.22
1-Week Range:
$1.92
$2.2612
52-Week Range:
$1.33
$250.00
Nucana Plc Adr Stock (NCNA) Company Profile
Compare NCNA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
2.18 | 8.99M | 0 | -38.99M | -9.67M | -134.61 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.85 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-30-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-03-22 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-22-20 | Initiated | Truist | Buy |
| Jul-24-20 | Initiated | Oppenheimer | Outperform |
| Aug-19-19 | Initiated | H.C. Wainwright | Buy |
| Oct-19-18 | Initiated | Piper Jaffray | Overweight |
| Oct-23-17 | Initiated | Citigroup | Buy |
| Oct-23-17 | Initiated | Jefferies | Buy |
| Oct-23-17 | Initiated | William Blair | Outperform |
View All
Nucana Plc Adr Stock (NCNA) Latest News
+5.10% for NuCana stock as overbought conditions emerge - Traders Union
+8.63% for NuCana stock as fresh highs prompt overbought signals - Traders Union
NuCana stock price forecast: $2.05–$2.40 range as NCNA gains 18.42% - Traders Union
NCNA News | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
-6.83% for NuCana stock as tight trading range restricts moves - Traders Union
NCNA Stock Chart | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
NuCana stock rises after bouncing from $1.60 support - Traders Union
NuCana plc Stock: Prodrug Technology Platform Targets Oncology Challenges for Long-Term Investor Val - AD HOC NEWS
Bearish signals and low breakout odds keep NuCana stock near resistance - Traders Union
Unusual Machines, NuCana, Navigator Holdings and other big stocks moving lower in Friday's pre-market session - MSN
NuCana plc Stock: Clinical-Stage Biotech Innovating Cancer Therapies with ProTide Technology - AD HOC NEWS
What is behind NuCana stock's recent drop in value today - tradersunion.com
-3.18% for NuCana stock as price stays pinned below key support levels - Traders Union
What triggered NuCana shares' latest price pullback - Traders Union
Negative indicators push NuCana stock lower amid continued selling activity - Traders Union
Selling pressure pushes NuCana stock lower in today's trading - Traders Union
What is behind NuCana stock's recent gain in value today - Traders Union
Technical weakness and oversold signals: NuCana stock falls 3.22% - Traders Union
NuCana shares see a dip: what is pressuring the stock - Traders Union
Unusual Machines, NuCana, Navigator Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NuCana (NASDAQ: NCNA) outlines 2025 losses, cash and oncology pipeline risks - Stock Titan
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update - ChartMill
Why is NuCana ADR stock down today? - tradersunion.com
Bearish technicals, heavy selling: NuCana stock slips 3.10% - Traders Union
NuCana stock slips 4.3% as bearish momentum builds ahead of earnings - Traders Union
Sustained bearish momentum and oversold signals — NuCana stock gains 3.14% - Traders Union
Why is NuCana stock up today? - Traders Union
NuCana shares see a dip — What is pressuring the stock - Traders Union
NuCana stock: Persistent volatility and downside risk drive further weakness - Traders Union
Oversold signals and resistance at $2.29 — NuCana stock gains 3.08% - Traders Union
NuCana shares see a jump — What is fueling the stock rise - Traders Union
What triggered NuCana shares latest price pullback - Traders Union
Persistent bearish signals and technical resistance — NuCana stock drops 4.63% - Traders Union
NuCana sees a dip — What is pressuring the stock - Traders Union
NuCana stock price forecast: Bear signals weigh as NCNA dips beneath key levels - Traders Union
NCNA Fundamental Analysis | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
Weak technical signals and persistent selling — NuCana stock falls 4.02% - Traders Union
What is behind NuCana recent drop in value today - Traders Union
What triggered NuCana latest price surge - Traders Union
NuCana stock: persistent negative momentum drives 3.40% gain despite mixed technicals - Traders Union
NuCana climbs today: Key reasons behind the rally - Traders Union
Buying pressure lifts NuCana higher in today trading - Traders Union
NuCana slides today: Key reasons behind the decline - Traders Union
NuCana stock price forecast: Further downside risk as NCNA drops 3.75% near support levels - Traders Union
NuCana stock: Bearish trends and weak support drive continued price decline - Traders Union
Nucana Plc Adr Stock (NCNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):